A link between promoter polymorphisms of the transforming
growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes
and relapsing-remitting multiple sclerosis

Transforming Growth Factor Β1 ◽

Promoter Polymorphisms ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Tgf Β1

2-31-19 Transforming growth factor β1 and soluble ICAM-1 in relapsing-remitting multiple sclerosis

Journal of the Neurological Sciences ◽

10.1016/s0022-510x(97)85431-7 ◽

1997 ◽

Vol 150 ◽

pp. S119

Author(s):

P.B. Carrieri ◽

V. Provitera ◽

L. Lavorgna ◽

C. Nappi ◽

O. Perrella

Keyword(s):

Multiple Sclerosis ◽

Growth Factor ◽

Transforming Growth Factor Β1 ◽

Relapsing Remitting ◽

Possible role of transforming growth factor-β in relapsing-remitting multiple sclerosis

Neurological Research ◽

10.1080/01616412.1997.11740866 ◽

1997 ◽

Vol 19 (6) ◽

pp. 599-600 ◽

Cited By ~ 14

Author(s):

P.B. Carrieri ◽

V. Provitera ◽

M. Perrella ◽

G. Tartaglia ◽

A. Busto ◽

...

Keyword(s):

Multiple Sclerosis ◽

Growth Factor ◽

Transforming Growth Factor Β ◽

Relapsing Remitting ◽

An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β

CNS & Neurological Disorders - Drug Targets ◽

10.2174/1871527314666150317225441 ◽

2015 ◽

Vol 14 (6) ◽

pp. 804-810 ◽

Cited By ~ 3

Author(s):

Rodica Balasa ◽

Smaranda Maier ◽

Septimiu Voidazan ◽

Adina Hutanu ◽

Zoltan Bajko ◽

...

Keyword(s):

Multiple Sclerosis ◽

Growth Factor ◽

Transforming Growth Factor Β ◽

Interleukin 10 ◽

Interleukin 17A ◽

Relapsing Remitting ◽

Intricate Mechanism ◽

Multiple Sclerosis Patients ◽

High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2013.01.012 ◽

2013 ◽

Vol 257 (1-2) ◽

pp. 82-89 ◽

Cited By ~ 2

Author(s):

Yifat Amir Levy ◽

Karin Mausner Fainberg ◽

Tali Amidror ◽

Keren Regev ◽

Eitan Auriel ◽

...

Keyword(s):

Multiple Sclerosis ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Immune Cells ◽

Relapsing Remitting ◽

Epidermal Growth ◽

Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response

CNS & Neurological Disorders - Drug Targets ◽

10.2174/1871527315666160615110739 ◽

2017 ◽

Vol 16 (1) ◽

pp. 93-101 ◽

Cited By ~ 4

Author(s):

Rodica Balasa ◽

Smaranda Maier ◽

Septimiu Voidazan ◽

Adina Hutanu ◽

Zoltan Bajko ◽

...

Keyword(s):

Multiple Sclerosis ◽

Growth Factor ◽

Treatment Response ◽

Interleukin 10 ◽

Transforming Growth Factor Beta1 ◽

Interleukin 17A ◽

Relapsing Remitting ◽

Multiple Sclerosis Patients ◽

Glial-derived transforming growth factor β1 (TGF-β1): a key factor in multiple sclerosis neuroinflammation

Neural Regeneration Research ◽

10.4103/1673-5374.293147 ◽

2021 ◽

Vol 16 (3) ◽

pp. 510 ◽

Cited By ~ 1

Author(s):

FernandoC Ortiz ◽

Coram Guevara

Keyword(s):

Multiple Sclerosis ◽

Growth Factor ◽

Transforming Growth Factor Β1 ◽

Key Factor ◽

Tgf Β1

In vivo effect of interferon-β 1a on interleukin-12 and TGF-β1 cytokines in patients with relapsing-remitting multiple sclerosis

Acta Neurologica Scandinavica ◽

10.1034/j.1600-0404.2002.01209.x ◽

2002 ◽

Vol 106 (1) ◽

pp. 44-46 ◽

Cited By ~ 15

Author(s):

J. Losy ◽

G. Michałowska-Wender

Keyword(s):

Multiple Sclerosis ◽

Interleukin 12 ◽

Interferon Β ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Tgf Β1

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

Yearbook of Neurology and Neurosurgery ◽

10.1016/j.yneu.2012.04.028 ◽

2012 ◽

Vol 2012 ◽

pp. 70-71

Author(s):

A. Minagar

Keyword(s):

Multiple Sclerosis ◽

Randomized Trial ◽

High Dose ◽

Vitamin D2 ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

High Dose Vitamin

Interferon beta-1b therapy in relapsing-remitting multiple sclerosis: Study design and preliminary results

Electroencephalography and Clinical Neurophysiology ◽

10.1016/s0013-4694(97)88414-7 ◽

1997 ◽

Vol 103 (1) ◽

pp. 99

Author(s):

G Salemi

Keyword(s):

Multiple Sclerosis ◽

Study Design ◽

Interferon Beta ◽

Preliminary Results ◽

Relapsing Remitting ◽

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(09)79049-0 ◽

2009 ◽

Vol 2009 ◽

pp. 99-103

Author(s):

O. Kantarci

Keyword(s):

Multiple Sclerosis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Relapsing Remitting ◽